A series of three sequential, randomized, controlled studies of repeated treatments with botulinum toxin type A for migraine prophylaxis.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Pain

• Publication date

  2006-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JPAIN.2006.03.002PMID 17018329
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nuevos fármacos antiepilépticos en la profilaxis de la migraña

  2007cited by this paper
• Botulinum Toxin Type A (BOTOX®) for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double‐Blind, Placebo‐Controlled Trial

  2005cited by this paper
• Topiramate in migraine prevention: results of a large controlled trial.

  2004cited by this paper
• Topiramate in Migraine Prevention: Results of a Large Controlled Trial

  2004cited by this paper
• Botulinum Toxin a for Chronic Daily Headache: A Randomized, Placebo-Controlled, Parallel Design Study

  2004cited by this paper
• Regulation of Calcitonin Gene‐Related Peptide Secretion From Trigeminal Nerve Cells by Botulinum Toxin Type A: Implications for Migraine Therapy

  2004cited by this paper
• Propranolol for Migraine Prophylaxis

  2004cited by this paper
• Botulinum Toxin A in the Prophylactic Treatment of Migraine – A Randomized, Double-Blind, Placebo-Controlled Study

  2004cited by this paper
• Mechanism of Action of Botulinum Toxin Type A in Migraine Prevention: A Pilot Study

  2004cited by this paper
• Treatment of Chronic Refractory Intractable Headache with Botulinum Toxin Type A: A Retrospective Study

  2004cited by this paper
• SF-36 health survey: Manual and interpretation guide

  2003cited by this paper
• Botulinum toxin type A in prophylactic treatment of migraine headaches: a preliminary study

  2003cited by this paper
• Single‐Site Botulinum Toxin Type A Injection for Elimination of Migraine Trigger Points

  2003cited by this paper
• Evidence for Antinociceptive Activity of Botulinum Toxin Type A in Pain Management

  2003cited by this paper
• Botulinum Toxin Type A as an Effective Prophylactic Treatment in Primary Headache Disorders

  2003cited by this paper
• Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Botulinum Toxin Type A for Patients with Glabellar Lines

  2003cited by this paper
• Long‐term efficacy of botulinum toxin A in treatment of various movement disorders over a 10‐year period

  2002cited by this paper
• The use of botulinum toxin in the treatment of headaches

  2002cited by this paper
• Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study.

  2002cited by this paper
• Re: “Botulinum Toxin Type A as a Migraine Preventive Treatment” (Silberstein S, Mathew N, Saper J, Jenkins S, for the BOTOX® Migraine Clinical Research Group. Headache. 2000;40:445‐450)

  2001cited by this paper
• Antiepileptic Drugs in Migraine Prevention

  2001cited by this paper
• Botulinum toxin therapy for pain and inflammatory disorders: mechanisms and therapeutic effects

  2001cited by this paper
• Evidence-based medicine: botulinum toxin A in migraine and tension-type headache

  2001cited by this paper
• Botulinum toxin type A (BOTOX) for treatment of migraine headaches: An open-label study

  2000cited by this paper
• Botulinum Toxin Type A as a Migraine Preventive Treatment

  2000cited by this paper
• SF-36 Health Survey Update

  2000cited by this paper
• Capsaicin-stimulated release of substance P from cultured dorsal root ganglion neurons: involvement of two distinct mechanisms.

  2000cited by this paper
• Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins.

  2000cited by this paper
• Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group.

  2000cited by this paper
• Further Development and Testing of the Migraine‐Specific Quality of Life (MSQOL) Measure

  2000cited by this paper
• A New Instrument to Assess the Long‐term Quality of Life Effects From Migraine: Development and Psychometric Testing of the MSQOL

  1996cited by this paper
• Validation of the Short Form 36 (SF-36) health survey questionnaire among stroke patients.

  1996cited by this paper
• Clinical validation of a quality of life questionnaire in angina pectoris patients.

  1995cited by this paper
• Botulinum toxin in the treatment of myofascial pain syndrome

  1994cited by this paper
• Treatment of myofascial pain with botulinum A toxin.

  1994cited by this paper
• Comparison of the Efficacy and Safety of Flunarizine to Propranolol in the Prophylaxis of Migraine

  1992cited by this paper
• Measuring Functioning and Well-Being: The Medical Outcomes Study Approach

  1992cited by this paper
• Double-blind study of botulinum toxin in spasmodic torticollis.

  1986cited by this paper
• Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery.

  1980cited by this paper
• PHENOTHIAZINE DYSKINESIA AFTER LEUCOTOMY.

  1964cited by this paper

• OnabotulinumtoxinA for the preventive treatment of episodic migraine: Results from the phase 3, multicenter randomized, double-blind, placebo-controlled phase of the PRECLUDE trial

  2025cites this paper
• Evidence-based preventive treatment of migraine.

  2024cites this paper
• Adverse and serious adverse events incidence of pharmacological interventions for managing chronic and episodic migraine in adults: a systematic review

  2024cites this paper
• Preventive drug treatments for adults with chronic migraine: a systematic review with economic modelling.

  2024cites this paper
• Nonpharmacologic Treatments for Chronic and Episodic Migraine: A Systematic Review and Meta-Analysis

  2023cites this paper
• The temporal trend of placebo response in migraine prevention from 1990 to 2021: a systematic literature review and meta-analysis with regression

  2023cites this paper
• Safety of Onabotulinumtoxin A in Chronic Migraine: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

  2023cites this paper
• OnabotulinumtoxinA for the treatment of headache: an updated review.

  2022cites this paper
• Chronic Migraine: A Narrative Review on the Use of Botulinum Toxin with Clinical Indications and Future Directions.

  2022cites this paper
• Beyond chronic migraine: a systematic review and expert opinion on the off-label use of botulinum neurotoxin type-A in other primary headache disorders

  2021influential citation
• OnabotulinumtoxinA for the prophylactic treatment of headaches in adult patients with chronic migraine: a safety evaluation

  2021cites this paper
• Is it possible to sort the disability of individuals with migraine based on the International Classification of Functioning, Disability and Health? — A Scoping Review

  2021cites this paper
• Therapeutic Management: When and What

  2020cites this paper
• Botulinum toxin type A wear-off phenomenon in chronic migraine patients: how long does the maximum efficiency last?

  2020cites this paper
• Impact of the botulinum-A toxin on prevention of adult migraine disorders.

  2020cites this paper
• Chronic migraine and Botulinum Toxin Type A: Where do paths cross?

  2020cites this paper
• Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine

  2019cites this paper
• Botulinum Toxin a Valuable Prophylactic Agent for Migraines and a Possible Future Option for the Prevention of Hormonal Variations-Triggered Migraines

  2019influential citation
• Botulinum Toxin Treatment in Clinical Medicine: A Disease-Oriented Approach

  2018cites this paper
• Chirurgie et migraine : revues de la littérature des traitements préventifs interventionnels relatifs à l'exercice du plasticien

  2018cites this paper
• Leczenie migreny przewlekłej — zalecenia opracowane przez Grupę Ekspertów Polskiego Towarzystwa Bólów Głowy i Sekcji Badania Bólu Polskiego Towarzystwa Neurologicznego na podstawie międzynarodowych zaleceń i najnowszej literatury

  2018cites this paper
• Botulinum Toxin Treatment of Migraine and Other Headaches

  2018cites this paper
• Management of Migraine Headaches: OnabotulinumtoxinA Injection

  2017cites this paper
• Management of Migraine Headaches: OnabotulinumtoxinA Injection Management of Migraine Headaches: OnabotulinumtoxinA Injection

  2017cites this paper
• Pharmacological Management of Migraine

  2017cites this paper
• 1 Practice guideline update : Botulinum neurotoxin for the treatment of blepharospasm , cervical dystonia , adult spasticity , and headache Report of the Guideline Development Subcommittee of the American Academy of Neurology

  2016cites this paper
• Chronic pain syndromes, mechanisms, and current treatments.

  2015cites this paper
• Migraine and Other Primary Headaches

  2015cites this paper
• Risk Factors for and Management of Medication-Overuse Headache

  2015cites this paper
• Botulinum toxins for the prevention of migraine in adults.

  2015cites this paper
• Effect of OnabotulinumtoxinA Injection on Depression in Chronic Migraine

  2015cites this paper
• Reporting of sample size calculations in analgesic clinical trials: ACTTION systematic review.

  2015cites this paper
• Current Status and Future Directions of Botulinum Neurotoxins for Targeting Pain Processing

  2015cites this paper
• Clinical Use of Botulinum Neurotoxins: Pain

  2014cites this paper
• Therapeutic use of botulinum toxin in migraine: mechanisms of action

  2014cites this paper
• [What is the optimal dose for the prophylactic treatment of chronic migraine patients?].

  2014cites this paper
• Differential Effectiveness of Placebo Treatments

  2014cites this paper
• Botulinum neurotoxins as therapeutics

  2014cites this paper
• Botulinum Toxin in Migraine Treatment.

  2013cites this paper
• Botulinum Toxin in the Management of Painful Conditions

  2013cites this paper
• Botulinum Toxin in Migraine Treatment

  2013cites this paper
• Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis.

  2013cites this paper
• Headache Direction and Aura Predict Migraine Responsiveness to Rimabotulinumtoxin B

  2013cites this paper
• Canadian Headache Society guideline for migraine prophylaxis.

  2012cites this paper
• Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine

  2012cites this paper
• Concurrent OnabotulinumtoxinA Treatment of Cervical Dystonia and Concomitant Migraine

  2012cites this paper
• Botulinum toxin in the treatment of post-traumatic headache - case study.

  2012cites this paper
• [Influence of treatments for migraine on quality of life: literature integrative review].

  2012cites this paper
• [Onabotulinumtoxin A in the treatment of chronic migraine].

  2012cites this paper
• Onabotulinumtoxin A in the Treatment of Migraine Headache

  2012cites this paper
• [Influence of treatments for migraine on quality of life: literature integrative review].

  2012cites this paper
• Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis.

  2012cites this paper
• Canadian Headache Society Guideline for Migraine Prophylaxis: Supplement 2

  2012cites this paper
• Botulinum toxin type-A effect as a preemptive treatment in a model of acute trigeminal pain: a pre-clinical double-blind and placebo-controlled study.

  2011cites this paper
• Treatment of refractory pain with botulinum toxins--an evidence-based review.

  2011cites this paper
• Chronic migraine: current concepts and ongoing treatments.

  2011cites this paper
• Are the current IHS guidelines for migraine drug trials being followed?

  2010cites this paper
• Method of Injection of OnabotulinumtoxinA for Chronic Migraine: A Safe, Well‐Tolerated, and Effective Treatment Paradigm Based on the PREEMPT Clinical Program

  2010cites this paper
• Botulinumtoxin bei Kopfschmerzen: Ende eines langen Weges?

  2010cites this paper
• Prophylaxis of migraine headache

  2010cites this paper
• Botulinum toxin for the treatment of headache: a promising path on a "dead end road"?

  2010cites this paper
• OnabotulinumtoxinA (botulinum toxin type-A) in the prevention of migraine

  2010cites this paper
• Botulinum Toxin in the Therapy for Headaches: Do We Now Have Enough Evidence?

  2010cites this paper
• Acute management of migraine.

  2010cites this paper
• Botulinum neurotoxin in the treatment of headache disorders.

  2010cites this paper
• Therapeutic guidelines for headache.

  2010cites this paper
• Submissions Method of Injection of OnabotulinumtoxinA for Chronic Migraine : A Safe , Well-Tolerated , and Effective Treatment Paradigm Based on the PREEMPT Clinical

  2010cites this paper
• Re-Engineering Clostridial Neurotoxins for the Treatment of Chronic Pain

  2010cites this paper
• Current practice and future directions in the prevention and acute management of migraine.

  2010cites this paper
• New drugs for migraine

  2009cites this paper
• THE ROLE OF INTERVENTIONAL THERAPY IN THE TREATMENT OF NEUROPATHIC PAIN

  2009cites this paper
• Chapter 29 – Unmet Needs and Challenges in the Therapeutic Use of Botulinum Neurotoxins

  2009cites this paper
• Chapter 17 – Botulinum Toxin in Headache Management

  2009cites this paper
• Adverse effects of medications commonly used in the treatment of migraine

  2009cites this paper
• Toxina botulinica como profilaxis de migraña

  2009cites this paper
• Pathophysiological basis of migraine prophylaxis.

  2009cites this paper
• Is botulinum toxin useful in treating headache? Yes

  2009cites this paper
• Is botulinum toxin useful in treating headache? No

  2009cites this paper
• Efficacy of Botulinum Toxin Type A for the Prophylaxis of Episodic Migraine Headaches: A Meta‐analysis of Randomized, Double‐Blind, Placebo‐Controlled Trials

  2009cites this paper
• Box 1 Migraine comorbid disease Cardiovascular Hypertension or hypotension Raynaud ’ s disease Mitral valve prolapse ( migraine with aura ) Angina or myocardial infarction Stroke Psychiatric Depression Mania Panic disorder Anxiety disorder Neurologic Epilepsy Essential tremor Positional vertigo Rest

  2009cites this paper
• Preventive migraine treatment.

  2009cites this paper
• Update on the Prophylaxis Update on the Prophylaxis

  2008cites this paper
• Questioning botulinum toxin for headache: reality or illusion.

  2008cites this paper
• Neuro-ophthalmologic Manifestations of Primary Headache Disorders

  2008cites this paper
• Update on the prophylaxis of migraine

  2008cites this paper
• Subcommittee of the American Academy of Neurology

  2008cites this paper
• Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review)

  2008cites this paper
• Botulinum Toxin Type A as Migraine Preventive Treatment in Patients Previously Failing Oral Prophylactic Treatment Due To Compliance Issues

  2008cites this paper
• Botulinum neurotoxins in the treatment of refractory pain

  2008cites this paper
• Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review) Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

  2008cites this paper
• The pharmacological management of migraine, part 2: preventative therapy.

  2008cites this paper
• Pediatric Migraine: Pharmacologic Agents for Prophylaxis

  2007cites this paper
• Role of botulinum toxin in migraine therapy

  2007cites this paper
• Botulinumtoxin A in der Migräneprophylaxe: Plazeboeffekt oder Wirksamkeit?

  2007cites this paper
• Evidence based medicine on the use of botulinum toxin for headache disorders

  2007cites this paper
• Newer aspects of migraine preventive therapies

  2007cites this paper